Literature DB >> 12163282

Attenuation of internal organ damages by exogenously administered epidermal growth factor (EGF) in burned rodents.

Jorge Berlanga1, Jorge Lodos, Pedro López-Saura.   

Abstract

Major burns are associated with multiple internal organ damages, including necrosis of the gastrointestinal mucosa. Failure of the intestinal barrier is a serious complication in burned patients. Epidermal growth factor (EGF) is a mitogenic polypeptide that stimulates wound repair and affords protection to the gastric mucosa. We examined whether a single systemic intervention with EGF prevents organ systems damages, following full-thickness scalds (25-30%) in rodents. Animals were randomly assigned to receive an intraperitoneal injection of EGF (30 microg/kg in mice, 10 microg/kg in rats) or saline solution, 30 min prior thermal injury in mice or after the cutaneous injury in rats. General clinical condition and mortality during 24h were recorded. Animals were autopsied and histopathological and histomorphometric studies were conducted. Mice treated with EGF exhibited a milder clinical evolution and acute lethality was significantly reduced as compared to saline counterparts (P<0.01). Histopathological and morphometric analysis showed that EGF significantly reduced intestinal necrosis and contributed to preserve jejunoileal architecture in mice (P<0.05) and rats (P<0.01). The onset of renal hemorrhagic foci was significantly reduced in EGF-treated groups (P<0.01). Lung damages appeared attenuated in EGF-treated animals. These data indicate the salutary effects of EGF by attenuating internal complications associated to thermal injuries. Further studies are warranted to fully elucidate the usefulness of this therapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12163282     DOI: 10.1016/s0305-4179(02)00023-2

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  8 in total

Review 1.  Can we protect the gut in critical illness? The role of growth factors and other novel approaches.

Authors:  Jessica A Dominguez; Craig M Coopersmith
Journal:  Crit Care Clin       Date:  2010-07       Impact factor: 3.598

2.  Pro-inflammatory effects of matrix metalloproteinase 7 in acute inflammation.

Authors:  R E Vandenbroucke; I Vanlaere; F Van Hauwermeiren; E Van Wonterghem; C Wilson; C Libert
Journal:  Mucosal Immunol       Date:  2013-10-16       Impact factor: 7.313

Review 3.  Diabetic lower extremity wounds: the rationale for growth factors-based infiltration treatment.

Authors:  Jorge Berlanga-Acosta
Journal:  Int Wound J       Date:  2011-09-13       Impact factor: 3.315

4.  Therapeutic effect of the combined use of growth hormone releasing peptide-6 and epidermal growth factor in an axonopathy model.

Authors:  Diana García Del Barco; Héctor Pérez-Saad; Valia Rodríguez; Javier Marín; Viviana Falcón; Jorge Martín; Danay Cibrian; Jorge Berlanga
Journal:  Neurotox Res       Date:  2010-02-19       Impact factor: 3.911

5.  Epidermal Growth Factor Improves Intestinal Integrity and Survival in Murine Sepsis Following Chronic Alcohol Ingestion.

Authors:  Nathan J Klingensmith; Benyam P Yoseph; Zhe Liang; John D Lyons; Eileen M Burd; Lindsay M Margoles; Michael Koval; Mandy L Ford; Craig M Coopersmith
Journal:  Shock       Date:  2017-02       Impact factor: 3.454

6.  Enterocyte-specific epidermal growth factor prevents barrier dysfunction and improves mortality in murine peritonitis.

Authors:  Jessica A Clark; Heng Gan; Alexandr J Samocha; Amy C Fox; Timothy G Buchman; Craig M Coopersmith
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-07-01       Impact factor: 4.052

7.  Epidermal growth factor treatment decreases mortality and is associated with improved gut integrity in sepsis.

Authors:  Jessica A Clark; Andrew T Clark; Richard S Hotchkiss; Timothy G Buchman; Craig M Coopersmith
Journal:  Shock       Date:  2008-07       Impact factor: 3.454

Review 8.  Endothelial cell signaling and ventilator-induced lung injury: molecular mechanisms, genomic analyses, and therapeutic targets.

Authors:  Ting Wang; Christine Gross; Ankit A Desai; Evgeny Zemskov; Xiaomin Wu; Alexander N Garcia; Jeffrey R Jacobson; Jason X-J Yuan; Joe G N Garcia; Stephen M Black
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-12-15       Impact factor: 5.464

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.